FONAR CORP

Delisted

CIK 355019fmd_1VFPP2TD4RV92J2RH4J064XH5XManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard

Coverage: Jul 01, 2010 to Mar 31, 2026, 63 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	73	78	82	87	86	90	98	99	103	104
Cost of revenue	1	1	1	–	–	–	–	–	–	–
Gross profit	72	77	81	–	–	–	–	–	–	–
Research and development	2	1	2	2	2	2	1	2	2	2
Selling, general and administrative	19	19	18	19	27	25	24	29	27	30
Operating income	–	–	–	–	–	(7)	5	11	5	–
Interest expense	(0)	0	(0)	0	0	0	0	0	0	0
Other non-operating income (expense)	0	(0)	(0)	0	0	1	1	(0)	0	0
Income before taxes	15	19	20	23	14	18	23	16	19	14
Income tax expense	(4)	(4)	(6)	2	2	4	6	4	5	3
Net income from continuing operations	14	19	20	22	14	17	22	15	17	11
Net income	16	20	21	15	8	10	12	9	11	8
Net income to common shareholders	–	–	–	–	–	10	12	9	–	–